The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma

被引：0

作者：

Barrington, Sally F. ^{[1
,2
]}

Trotman, Judith ^{[3
]}

机构：

[1] Kings Coll London, London SE1 7EH, England

[2] Kings Coll London, Kings Hlth Partners, Guys & St Thomas PET Ctr, Sch Biomed & Imaging, London SE1 7EH, England

[3] Univ Sydney, Dept Haematol, Concord Repatriat Gen Hosp, Sydney, NSW, Australia

来源：

LANCET HAEMATOLOGY | 2021年 / 8卷 / 01期

基金：

英国工程与自然科学研究理事会; 英国医学研究理事会;

关键词：

B-CELL LYMPHOMA; POSITRON-EMISSION-TOMOGRAPHY; METABOLIC TUMOR VOLUME; END-OF-TREATMENT; BURDEN FOLLICULAR LYMPHOMA; BONE-MARROW BIOPSY; BASE-LINE; FDG-PET; RESPONSE ASSESSMENT; PROGNOSTIC VALUE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This Review focuses on the use of F-18-fluorodeoxyglucose (F-18-FDG) PET in the assessment of diffuse large B-cell lymphoma, follicular lymphoma, and peripheral T-cell lymphoma. PET is important for staging and prognostication with stage migration compared with CT. Better outcomes for patients with early stage diffuse large B-cell lymphoma and follicular lymphoma suggests better delineation of disease has translated to improved outcomes in such patients beyond simple stage migration. The aim of treatment of diffuse large B-cell lymphoma and peripheral T-cell lymphoma is potential cure, during which PET is mainly used to assess remission. Interim PET can assess chemosensitivity in these lymphomas, but it does not predict treatment success sufficiently well to enable treatment modification, particularly in the absence of more effective therapies for patients who remain PET-positive on interim scanning. In follicular lymphoma, traditionally viewed as an incurable lymphoma, the aim of treatment is to control disease for several years, while maintaining quality of life. PET can predict prognosis for patients with follicular lymphoma with high tumour burden at the end of induction chemotherapy, and it is being evaluated as a platform for response-adapted treatment of follicular lymphoma.

引用

页码：E80 / E93

页数：14

共 78 条

[1] Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma [J].

Abe, Yoshiaki ;

Kitadate, Akihiro ;

Usui, Yoshiaki ;

Narita, Kentaro ;

Kobayashi, Hiroki ;

Miura, Daisuke ;

Takeuchi, Masami ;

O'uchi, Eri ;

O'uchi, Toshihiro ;

Matsue, Kosei .

CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) :E336-E341

[2] Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma [J].

Albano, Domenico ;

Bosio, Giovanni ;

Bianchetti, Nicola ;

Pagani, Chiara ;

Re, Alessandro ;

Tucci, Alessandra ;

Giubbini, Raffaele ;

Bertagna, Francesco .

ANNALS OF NUCLEAR MEDICINE, 2019, 33 (07) :449-458

[3] The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study [J].

Alzahrani, M. ;

El-Galaly, T. C. ;

Hutchings, M. ;

Hansen, J. W. ;

Loft, A. ;

Johnsen, H. E. ;

Iyer, V. ;

Wilson, D. ;

Sehn, L. H. ;

Savage, K. J. ;

Connors, J. M. ;

Gascoyne, R. D. ;

Johansen, P. ;

Clasen-Linde, E. ;

Brown, P. ;

Villa, D. .

ANNALS OF ONCOLOGY, 2016, 27 (06) :1095-1099

[4]

[Anonymous], 2018, BLOOD S1

[5] Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project [J].

Bailly, Clement ;

Carlier, Thomas ;

Berriolo-Riedinger, Alina ;

Casasnovas, Olivier ;

Gyan, Emmanuel ;

Meignan, Michel ;

Moreau, Anne ;

Burroni, Barbara ;

Djaileb, Loic ;

Gressin, Remy ;

Devillers, Anne ;

Lamy, Thierry ;

Thieblemont, Catherine ;

Hermine, Olivier ;

Kraeber-Bodere, Francoise ;

Le Gouill, Steven ;

Bodet-Milin, Caroline .

HAEMATOLOGICA, 2020, 105 (01) :E33-E36

[6] Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden [J].

Barrington, Sally E. ;

Meignan, Michel .

JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (08) :1096-1102

[7] FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas [J].

Barrington, Sally F. ;

Kluge, Regine .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S97-S110

[8] Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].

Barrington, Sally F. ;

Mikhaeel, N. George ;

Kostakoglu, Lale ;

Meignan, Michel ;

Hutchings, Martin ;

Mueeller, Stefan P. ;

Schwartz, Lawrence H. ;

Zucca, Emanuele ;

Fisher, Richard I. ;

Trotman, Judith ;

Hoekstra, Otto S. ;

Hicks, Rodney J. ;

O'Doherty, Michael J. ;

Hustinx, Roland ;

Biggi, Alberto ;

Cheson, Bruce D. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+

[9]

Barrington SF, 2018, PET MRI IN ONCOLOGY, P373

[10] Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma [J].

Batlevi, Connie L. ;

Sha, Fushen ;

Alperovich, Anna ;

Ni, Ai ;

Smith, Katy ;

Ying, Zhitao ;

Getreciano, John F. ;

Hamlin, Paul A. ;

Horwitz, Steve M. ;

Joffe, Erel ;

Kumar, Anita ;

Matasar, Matthew J. ;

Moskowitz, Alison J. ;

Moskowitz, Craig H. ;

Noy, Ariela ;

Owens, Colette ;

Palomba, Lia M. ;

Straus, David ;

von Keudell, Gottfried ;

Zelenetz, Andrew D. ;

Seshan, Venkatraman E. ;

Luminari, Stefano ;

Marcheselli, Luigi ;

Federico, Massimo ;

Younes, Anas .

EUROPEAN JOURNAL OF CANCER, 2020, 126 :78-90

← 1 2 3 4 5 6 7 8 →